Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our pharmaceutical grade Tirzepatide features a purity level of 99+% and is supplied as a white crystalline powder. The product shows greater affinity for GIP receptors than GLP-1 receptors, producing enhanced hyperglycemia reduction effects. This dual agonist behavior makes it particularly valuable for metabolic disorder research.
We offer flexible customization options including various vial sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 50mg) and private labeling services. All batches undergo rigorous quality control testing to ensure consistency and purity for research applications.
When you need to get tirzepatide online for your research projects, our manufacturing facility provides reliable supply with competitive wholesale pricing. The product is strictly for laboratory research purposes only.